Jounce Therapeutics News - JNCE

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Jounce Therapeutics Inc JNCE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.72 12.5% 6.48 5.845 6.50 5.95 5.76 17:15:00
more quote information »

Recent News

Date Time Source Heading
6/04/202008:08EDGARCurrent Report Filing (8-k)
6/04/202008:00GLOBEJounce Therapeutics Regains Worldwide Rights to JTX-8064..
6/02/202008:14EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/02/202008:00GLOBEJounce Therapeutics to Hold Virtual Meeting of Stockholders
5/15/202008:00GLOBEJounce Therapeutics to Present First Preclinical Data on..
5/06/202013:57EDGARQuarterly Report (10-q)
5/06/202007:16EDGARCurrent Report Filing (8-k)
5/06/202006:30GLOBEJounce Therapeutics Reports First Quarter 2020 Financial..
4/29/202016:39EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/29/202016:37EDGARProxy Statement (definitive) (def 14a)
4/29/202008:00GLOBEJounce Therapeutics to Announce First Quarter 2020 Financial..
4/09/202011:00EDGAROther Filing
4/09/202011:00EDGAROther Filing
4/07/202007:56EDGARCurrent Report Filing (8-k)
2/27/202012:16EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/27/202012:11EDGARAnnual Report (10-k)
2/27/202007:16EDGARCurrent Report Filing (8-k)
2/27/202006:30GLOBEJounce Therapeutics Reports Fourth Quarter and Full Year..
2/26/202008:00GLOBEJounce Therapeutics to Present at Upcoming Investor..
2/21/202013:25GLOBEJounce Therapeutics to Announce Fourth Quarter and Full Year..
2/06/202008:00GLOBEJounce Therapeutics Presents New Vopratelimab Predictive..
1/23/202008:09EDGARStatement of Changes in Beneficial Ownership (4)
1/23/202008:07EDGARInitial Statement of Beneficial Ownership (3)
1/23/202008:06EDGARCurrent Report Filing (8-k)
1/23/202008:00GLOBEJounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E.,..
1/13/202008:02EDGARCurrent Report Filing (8-k)
1/10/202008:54EDGARStatement of Changes in Beneficial Ownership (4)
1/10/202008:54EDGARStatement of Changes in Beneficial Ownership (4)
1/10/202008:54EDGARStatement of Changes in Beneficial Ownership (4)
1/10/202008:54EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202008:00GLOBEJounce Therapeutics to Present at the 38th Annual J.P...
1/08/202016:57EDGARStatement of Changes in Beneficial Ownership (4)
12/26/201917:08EDGARStatement of Changes in Beneficial Ownership (4)
12/19/201915:00GLOBEJounce Therapeutics to Present New Data on a Potential..
12/17/201917:01EDGARCurrent Report Filing (8-k)
12/17/201916:57EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/07/201912:08EDGARQuarterly Report (10-q)
11/07/201906:43EDGARCurrent Report Filing (8-k)
11/07/201906:30GLOBEJounce Therapeutics Reports Third Quarter 2019 Financial..
11/05/201908:05GLOBEJounce Therapeutics to Present Safety and Preliminary..
10/31/201908:00GLOBEJounce Therapeutics to Announce Third Quarter 2019 Financial..
10/01/201918:01GLOBEJounce Therapeutics to Present Two Posters from the JTX-4014..
9/17/201908:00GLOBEJounce Therapeutics Names Jacquelyn Fahey Sandell as Chief..
9/04/201908:52EDGARCurrent Report Filing (8-k)
8/28/201908:00GLOBEJounce Therapeutics to Present at Upcoming Investor..
8/07/201911:25EDGARQuarterly Report (10-q)
8/07/201907:17EDGARCurrent Report Filing (8-k)
8/07/201906:30GLOBEJounce Therapeutics Reports Second Quarter 2019 Financial..
7/31/201908:00GLOBEJounce Therapeutics to Announce Second Quarter 2019..
7/23/201916:05EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
JNCE
Jounce The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.